I am one of the founders of Inphasol, Inc., which is developing a novel platform technology for protein overproduction and delivery. Inphasol is a spin-off company from the Center for Phage Technology at Texas A&M University. I have over 22 years of experience developing phage technology in academic and biotech startup settings. I hold a Ph.D. in food microbiology from the University of Guelph in Canada and have worked as the program director at the Center for Phage Technology since 2016.
